NASDAQ : TBPH
Theravance Biopharma, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 17.03 USD (At close: Sep 23, 2026) · Market cap 884.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Theravance Biopharma, Inc. (TBPH) reported revenue of 104.31M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 104.31M | 107.46M | 64.38M | 57.42M | 51.35M | 55.31M |
| Cost of Revenue | 26.01M | 37.41M | 37.64M | 40.62M | 63.39M | 193.66M |
| Gross Profit | 78.30M | 70.05M | 26.74M | 16.80M | -12.05M | -138.35M |
| Selling, General & Admin | 68.75M | 73.65M | 69.17M | 70.09M | 67.07M | 99.30M |
| Operating Expenses | 68.75M | 73.65M | 69.17M | 70.45M | 67.07M | 99.30M |
| Operating Income | 9.55M | -3.60M | -42.44M | -53.65M | -79.12M | -237.64M |
| Interest Expense | -1.16M | -2.46M | -2.55M | -2.35M | -6.37M | -8.55M |
| Interest & Investment Income | 14.38M | 10.27M | 4.98M | 9.02M | 6.74M | 2.01M |
| Currency Exchange Gain (Loss) | -100.00K | -100.00K | -100.00K | 100.00K | -900.00K | -900.00K |
| Other Non Operating Income (Expenses) | -75.14M | |||||
| EBT Excluding Unusual Items | -52.47M | 4.11M | -40.10M | -46.88M | -79.65M | -245.08M |
| Merger & Restructuring Charges | -7.66M | -2.39M | -12.84M | -20.14M | ||
| Gain (Loss) on Sale of Assets | 2.71M | |||||
| Asset Writedown | -4.51M | |||||
| Other Unusual Items | 119.05M | 125.14M | -3.03M | |||
| Pretax Income | 58.92M | 129.25M | -44.61M | -49.27M | -92.81M | -265.22M |
| Income Tax Expense | 5.11M | 23.35M | 11.80M | 5.92M | 9.00K | -151.00K |
| Earnings From Continuing Operations | 53.81M | 105.89M | -56.42M | -55.19M | -92.82M | -265.07M |
| Earnings From Discontinued Operations | 964.96M | 65.64M | ||||
| Net Income | 53.81M | 105.89M | -56.42M | -55.19M | 872.13M | -199.43M |
| Net Income to Common | 53.81M | 105.89M | -56.42M | -55.19M | 872.13M | -199.43M |
| Shares Outstanding (Basic) | 51.08M | 50.32M | 48.85M | 55.30M | 73.59M | 69.46M |
| Shares Outstanding (Diluted) | 51.90M | 51.51M | 48.85M | 55.30M | 73.59M | 69.46M |
| EPS (Basic) | 1.05 | 2.10 | -1.15 | -1.00 | 11.85 | -2.87 |
| EPS (Diluted) | 1.05 | 2.06 | -1.15 | -1.00 | 11.85 | -2.87 |
| Free Cash Flow | 53.73M | 238.50M | -11.87M | -29.48M | -187.56M | -211.26M |
| Free Cash Flow Per Share | 1.03 | 4.63 | -0.24 | -0.53 | -2.55 | -3.04 |
| Gross Margin | 75.06% | 65.19% | 41.53% | 29.26% | -23.46% | -250.12% |
| Operating Margin | 9.16% | -3.35% | -65.91% | -93.43% | -154.09% | -429.65% |
| Profit Margin | 51.58% | 98.54% | -87.63% | -96.11% | 1,698.54% | -360.55% |
| Free Cash Flow Margin | 51.51% | 221.93% | -18.43% | -51.35% | -365.29% | -381.96% |
| EBITDA | 11.10M | -1.98M | -40.73M | -51.65M | -76.08M | -232.83M |
| EBITDA Margin | 10.64% | -1.84% | -63.26% | -89.94% | -148.18% | |
| D&A For EBITDA | 1.55M | 1.63M | 1.71M | 2.00M | 3.04M | 4.81M |
| EBIT | 9.55M | -3.60M | -42.44M | -53.65M | -79.12M | -237.64M |
| EBIT Margin | 9.16% | -3.35% | -65.91% | -93.43% | -154.09% | |
| Effective Tax Rate | 8.67% | 18.07% | ||||
| Revenue as Reported | 104.31M | 107.46M | 64.38M | 57.42M | 51.35M | 55.31M |
| Advertising Expenses | 5.10M | 4.30M | 5.10M | 8.00M | 9.30M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 219.77M | 167.81M | 37.80M | 39.55M | 298.17M | 89.96M |
| Short-Term Investments | 167.89M | 147.55M | 50.55M | 62.88M | 29.31M | 83.51M |
| Cash & Short-Term Investments | 387.66M | 315.36M | 88.35M | 102.43M | 327.48M | 173.47M |
| Accounts Receivable | 20.38M | 45.54M | 18.44M | 17.47M | 16.79M | 14.06M |
| Other Receivables | 50.00M | 50.00M | ||||
| Receivables | 20.38M | 95.54M | 68.44M | 17.47M | 16.79M | 14.06M |
| Prepaid Expenses | 8.62M | 7.56M | 4.28M | 13.64M | 9.20M | 18.81M |
| Other Current Assets | 43.53M | |||||
| Total Current Assets | 416.66M | 418.46M | 161.07M | 133.54M | 353.46M | 249.87M |
| Property, Plant & Equipment | 27.09M | 30.27M | 35.77M | 45.35M | 52.00M | 53.35M |
| Long-Term Investments | 11.13M | |||||
| Other Long-Term Assets | 26.01M | 25.72M | 157.32M | 203.10M | 201.94M | 71.60M |
| Total Assets | 469.77M | 485.57M | 354.16M | 382.00M | 607.40M | 374.82M |
| Accounts Payable | 652.00K | 2.57M | 2.24M | 1.52M | 1.55M | 3.10M |
| Accrued Expenses | 19.32M | 19.50M | 13.28M | 12.83M | 20.41M | 37.95M |
| Current Portion of Long-Term Debt | 16.94M | |||||
| Current Portion of Leases | 10.79M | 10.95M | 10.71M | 3.92M | 6.75M | 503.00K |
| Current Income Taxes Payable | 5.29M | 5.85M | ||||
| Current Unearned Revenue | 98.00K | |||||
| Other Current Liabilities | 6.49M | |||||
| Total Current Liabilities | 30.77M | 38.30M | 32.09M | 24.77M | 28.71M | 58.59M |
| Long-Term Debt | 599.39M | |||||
| Long-Term Leases | 27.77M | 31.76M | 39.11M | 45.24M | 45.41M | 52.68M |
| Long-Term Unearned Revenue | 192.00K | 310.00K | ||||
| Other Long-Term Liabilities | 121.53M | 118.79M | 107.42M | 99.00M | 91.29M | 2.42M |
| Total Liabilities | 180.06M | 188.85M | 178.62M | 169.00M | 165.60M | 713.39M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | ||
| Additional Paid-In Capital | 1.16B | 1.16B | 1.14B | 1.12B | 1.30B | 1.39B |
| Retained Earnings | -870.46M | -859.63M | -965.52M | -909.10M | -853.91M | -1.73B |
| Comprehensive Income & Other | -76.00K | 61.00K | 7.00K | -65.00K | -15.00K | |
| Shareholders' Equity | 289.70M | 296.72M | 175.54M | 213.00M | 441.80M | -338.57M |
| Total Liabilities & Equity | 469.77M | 485.57M | 354.16M | 382.00M | 607.40M | 374.82M |
| Total Debt | 38.57M | 42.70M | 49.82M | 49.16M | 52.16M | 669.52M |
| Net Cash (Debt) | 349.09M | 283.78M | 38.53M | 53.27M | 275.32M | -496.05M |
| Net Cash Per Share | 6.73 | 5.51 | 0.79 | 0.96 | 3.74 | -7.14 |
| Filing Date Shares Outstanding | 51.92M | 51.49M | 49.47M | 48.16M | 62.86M | 74.70M |
| Total Common Shares Outstanding | 51.89M | 51.07M | 49.47M | 48.09M | 65.23M | 74.44M |
| Working Capital | 385.90M | 380.16M | 128.98M | 108.77M | 324.75M | 191.28M |
| Book Value Per Share | 5.58 | 5.81 | 3.55 | 4.43 | 6.77 | -4.55 |
| Tangible Book Value | 289.70M | 296.72M | 175.54M | 213.00M | 441.80M | -338.57M |
| Tangible Book Value Per Share | 5.58 | 5.81 | 3.55 | 4.43 | 6.77 | -4.55 |
| Machinery | 3.67M | 3.74M | 3.68M | 19.04M | 26.03M | |
| Leasehold Improvements | 25.28M | 25.32M | 26.21M | 24.58M | 24.05M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 53.81M | 105.89M | -56.42M | -55.19M | 872.13M | -199.43M |
| Depreciation & Amortization | 5.79M | 5.64M | 6.12M | 6.15M | 7.02M | 8.60M |
| Loss (Gain) From Sale of Assets | 35.00K | 34.00K | 1.35M | -2.72M | 39.00K | |
| Asset Writedown & Restructuring Costs | 4.51M | |||||
| Loss (Gain) From Sale of Investments | -3.62M | -2.83M | -2.51M | -1.90M | ||
| Stock-Based Compensation | 19.55M | 18.48M | 21.39M | 25.37M | 39.73M | 62.06M |
| Other Operating Activities | -986.00K | -9.15M | -5.03M | 5.56M | -960.95M | -67.50M |
| Change in Accounts Receivable | 1.54M | -27.10M | -966.00K | -689.00K | -2.72M | 1.80M |
| Change in Accounts Payable | -1.02M | 326.00K | 750.00K | 6.00K | -1.61M | -3.53M |
| Change in Unearned Revenue | -216.00K | -192.00K | -11.46M | |||
| Change in Income Taxes | -15.45M | 10.48M | 9.91M | 1.10M | 63.95M | -189.00K |
| Change in Other Net Operating Assets | -5.87M | 136.76M | 10.66M | -8.54M | -17.08M | -26.17M |
| Operating Cash Flow | 53.74M | 238.54M | -11.54M | -27.00M | -186.99M | -207.86M |
| Capital Expenditures | -8.00K | -42.00K | -332.00K | -2.49M | -572.00K | -3.41M |
| Sale of Property, Plant & Equipment | 1.51M | 4.58M | 6.00K | |||
| Investment in Securities | -107.46M | -105.24M | 14.91M | -31.72M | 54.87M | 127.89M |
| Other Investing Activities | -2.29M | 1.10B | ||||
| Investing Cash Flow | -107.47M | -105.28M | 12.28M | -32.70M | 1.15B | 124.49M |
| Long-Term Debt Repaid | -631.60M | -10.73M | ||||
| Net Debt Issued (Repaid) | -631.60M | -10.73M | ||||
| Issuance of Common Stock | 2.14M | 786.00K | 607.00K | 618.00K | 802.00K | 111.65M |
| Repurchase of Common Stock | -10.58M | -4.03M | -3.10M | -199.55M | -132.28M | -9.06M |
| Other Financing Activities | 4.28M | |||||
| Financing Cash Flow | -8.44M | -3.25M | -2.50M | -198.93M | -758.81M | 91.86M |
| Net Cash Flow | -62.16M | 130.01M | -1.75M | -258.63M | 208.21M | 8.50M |
| Free Cash Flow | 53.73M | 238.50M | -11.87M | -29.48M | -187.56M | -211.26M |
| Free Cash Flow Margin | 51.51% | 221.93% | -18.43% | -51.35% | -365.29% | -381.96% |
| Free Cash Flow Per Share | 1.03 | 4.63 | -0.24 | -0.53 | -2.55 | -3.04 |
| Levered Free Cash Flow | 5.30M | -4.12M | -42.00M | -12.22M | 24.00M | -115.85M |
| Unlevered Free Cash Flow | 6.02M | -2.58M | -40.41M | -10.75M | 27.98M | -110.50M |
| Cash Interest Paid | 22.24M | 39.03M | ||||
| Cash Income Tax Paid | 24.55M | 27.88M | 109.00K | 24.00K | 117.97M | -4.09M |
| Change in Working Capital | -20.80M | 120.47M | 20.36M | -8.34M | 42.35M | -39.55M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 884.18M | 948.08M | 462.73M | 559.73M | 754.54M | 814.37M |
| Enterprise Value | 535.09M | 659.97M | 416.35M | 476.56M | 319.79M | 1.27B |
| Last Close Price | 17.03 | 18.71 | 9.41 | 11.24 | 11.22 | 11.05 |
| PE Ratio | 16.30 | 8.95 | 0.86 | |||
| Forward PE | 8.41 | 25.83 | 29.96 | 29.96 | 29.96 | |
| PS Ratio | 8.48 | 8.82 | 7.19 | 9.75 | 14.70 | 14.72 |
| PB Ratio | 3.05 | 3.19 | 2.64 | 2.63 | 1.71 | -2.40 |
| P/TBV Ratio | 3.05 | 3.19 | 2.64 | 2.63 | 1.71 | |
| P/FCF Ratio | 16.45 | 3.98 | ||||
| P/OCF Ratio | 16.45 | 3.97 | ||||
| EV/Sales Ratio | 5.13 | 6.14 | 6.47 | 8.30 | 6.23 | 22.95 |
| EV/FCF Ratio | 9.96 | 2.77 | ||||
| Debt / Equity Ratio | 0.13 | 0.14 | 0.28 | 0.23 | 0.12 | -1.98 |
| Debt / FCF Ratio | 0.72 | 0.18 | ||||
| Net Debt / Equity Ratio | -1.21 | -0.96 | -0.22 | -0.25 | -0.62 | -1.47 |
| Net Debt / EBITDA Ratio | -31.44 | 143.61 | 0.95 | 1.03 | 3.62 | -2.13 |
| Net Debt / FCF Ratio | -6.50 | -1.19 | 3.25 | 1.81 | 1.47 | -2.35 |
| Asset Turnover | 0.23 | 0.26 | 0.17 | 0.12 | 0.10 | 0.13 |
| Quick Ratio | 13.26 | 10.73 | 4.89 | 4.84 | 11.99 | 3.20 |
| Current Ratio | 13.54 | 10.93 | 5.02 | 5.39 | 12.31 | 4.26 |
| Return on Equity (ROE) | 20.91% | 44.84% | -29.04% | -16.86% | -179.84% | |
| Return on Assets (ROA) | 1.33% | -0.54% | -7.21% | -6.78% | -10.07% | -35.20% |
| Return on Invested Capital (ROIC) | -3.66% | -28.60% | -32.89% | -32.78% | -71.83% | |
| Return on Capital Employed (ROCE) | 2.20% | -0.80% | -13.20% | -15.00% | -13.70% | -75.10% |
| Earnings Yield | 6.09% | 11.17% | -12.19% | -9.86% | 115.58% | -24.49% |
| FCF Yield | 6.08% | 25.16% | -2.56% | -5.27% | -24.86% | -25.94% |
| Buyback Yield / Dilution | -3.94% | -5.45% | 11.67% | 24.85% | -5.95% | -11.41% |